Form 4: Olema Pharmaceuticals' Chief Medical Officer Exercises Stock Options

Chief Medical Officer of Olema Pharmaceuticals, Naseem Zojwalla, exercised stock options on March 18, 2024, acquiring 13,700 shares of common stock.

Summary

• Naseem Zojwalla, the Chief Medical Officer of Olema Pharmaceuticals, exercised stock options on March 18, 2024.
• This transaction resulted in the acquisition of 13,700 shares of Olema Pharmaceuticals' common stock at a price of $4.87 per share.
• Following the transaction, Zojwalla directly owns 80,364 shares of common stock.
• The exercised stock options were part of a grant that vests over time, with 25% vesting on February 1, 2024, and the remainder vesting monthly thereafter, contingent upon continuous service.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives and their holdings in the company's stock.

Stakeholder Impact

• The transaction has a minor impact on shareholders as it reflects an executive's confidence in the company.
• There is no immediate impact on employees, customers, suppliers, or creditors.

Key Dates